Now showing items 1-2 of 2

    • Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk 

      Petenkaya, A.; Bozkurt, B.; Akilli-Ozturk, O.; Kaya, H. S.; Gur-Dedeoglu, B.; Yulug, I. G. (Delinasios GJ & CO, 2006)
      Background: A T-to-G polymorphism (SNP309) at the promoter region of MDM2 has been recently reported to extend the Sp1 binding site that positively regulates the MDM2 transcription level and consequently, its expression ...
    • MDM2 T309G polymorphism is associated with bladder cancer 

      Onat, O. E.; Tez, M.; Özçelik, T.; Törüner, G. A. (International Institute of Anticancer Research, 2006)
      Recently, a functional T to G polymorphism at nucleotide 309 in the promoter region of the MDM2 gene (rs: 2279744, SNP 309) has been identified. This polymorphism has an impact on the expression of the MDM2 gene, which is ...